603301 振德醫療
按盤價 
24.130 +2.020 (+9.136%) | 2024/06 - 中期 人民幣(K¥) | 與去年同期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 2,042,420 | -11.44% | 4,127,044 | 6,137,634 | 5,091,572 | 10,398,546 | |
| 減：營業總成本 | 1,832,891 | -10.61% | 3,740,278 | 5,246,611 | 4,356,103 | 6,786,088 | |
| 其中:營業成本 | 1,319,158 | -12.35% | 2,694,611 | 3,991,505 | 3,319,139 | 5,514,701 | |
| 財務費用 | (10,764) | -55.91% | (20,798) | 2,073 | 27,165 | 105,028 | |
| 資產減值損失 | (22,006) | -17.97% | (207,460) | (75,560) | (36,072) | (101,452) | |
| 公允價值變動收益 | (927) | -93.34% | (21,065) | (11,220) | (2,704) | (2,835) | |
| 投資收益 | 1,275 | -114.97% | 6,801 | (59,842) | 36,736 | 14,399 | |
| 其中：對聯營企業和合營企業的投資收益 | (393) | -0.74% | (632) | (2,196) | (302) | (271) | |
| 營業利潤 | 201,256 | -23.80% | 225,948 | 812,810 | 821,973 | 3,537,011 | |
| 利潤總額 | 197,824 | -24.39% | 218,892 | 801,716 | 819,949 | 3,533,087 | |
| 減：所得稅費用 | 30,536 | 62.23% | 5,492 | 99,959 | 99,002 | 561,187 | |
| 淨利潤 | 167,288 | -31.11% | 213,400 | 701,758 | 720,947 | 2,971,900 | |
| 減：非控股權益 | 6,178 | 13.06% | 15,001 | 21,879 | 125,085 | 422,447 | |
| 股東淨利潤 | 161,109 | -32.13% | 198,399 | 679,878 | 595,862 | 2,549,453 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.600 | -32.58% | 0.740 | 2.870 | 2.640 | 12.500 | |
| 每股派息 (元) * | -- | -- | 1.250 | 0.750 | 0.600 | 2.300 | |
| 每股淨資產 (元) * | 20.378 | -3.32% | 20.137 | 20.798 | 17.899 | 18.410 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | -- | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
